Company logo

CL - Colgate-Palmolive Company

NYSE -> Consumer Defensive -> Household & Personal Products
New York, United States
Type: Equity

CL price evolution
CL
(in millions $) 31 Jan 2024 30 Sep 2023 30 Jun 2023 31 Mar 2023
Current assets
Cash $966 $951 $819 $867
Short term investments
Net receivables $1586 $1577 $1656 $1590
Inventory $1934 $1931 $2039 $2110
Total current assets $5279 $5357 $5437 $5466
Long term investments
Property, plant & equipment $4582 $4409 $4431 $4363
Goodwill & intangible assets $5297 $5188 $5274 $5293
Total noncurrent assets $11114 $10686 $10790 $10707
Total investments
Total assets $16393 $16043 $16227 $16173
Current liabilities
Accounts payable $1698 $1482 $1544 $1609
Deferred revenue
Short long term debt $330 $34 $35 $37
Total current liabilities $4741 $4602 $4632 $4441
Long term debt $8219 $8690 $8954 $8870
Total noncurrent liabilities $10695 $11035 $11280 $11307
Total debt $8549 $8724 $8989 $8907
Total liabilities $15436 $15637 $15912 $15748
Shareholders' equity
Retained earnings $25289 $24571 $24258 $24153
Other shareholder equity -$3937 -$3974 -$3935 -$3983
Total shareholder equity $609 -$9 -$64 -$6
(in millions $) 31 Jan 2024 31 Jan 2023 31 Dec 2021 31 Dec 2020
Current assets
Cash $966 $775 $832 $888
Short term investments $37
Net receivables $1586 $1504 $1297 $1264
Inventory $1934 $2074 $1692 $1673
Total current assets $5279 $5113 $4397 $4338
Long term investments $75
Property, plant & equipment $4582 $4307 $3730 $3716
Goodwill & intangible assets $5297 $5272 $5746 $6718
Total noncurrent assets $11114 $10618 $10643 $11582
Total investments
Total assets $16393 $15731 $15040 $15920
Current liabilities
Accounts payable $1698 $1551 $1479 $1393
Deferred revenue
Short long term debt $330 $25 $51 $267
Total current liabilities $4741 $3979 $4051 $4404
Long term debt $8219 $8766 $7194 $7334
Total noncurrent liabilities $10695 $10921 $10018 $10415
Total debt $8549 $8766 $7245 $7601
Total liabilities $15436 $15330 $14069 $14819
Shareholders' equity
Retained earnings $25289 $24573 $24350 $23699
Other shareholder equity -$3937 $401 -$4386 -$4345
Total shareholder equity $609 $401 $609 $743
(in millions $) 31 Jan 2024 30 Sep 2023 30 Jun 2023 31 Mar 2023
Revenue
Total revenue $4915 $4822 $4770
Cost of revenue $2038 $2035 $2058
Gross Profit $2877 $2787 $2712
Operating activities
Research & development
Selling, general & administrative $1822 $1768 $1758
Total operating expenses $1848 $1813 $1803
Operating income $1029 $974 $909
Income from continuing operations
EBIT $975 $913 $573
Income tax expense $209 $353 $147
Interest expense $58 $58 $54
Net income
Net income $708 $502 $372
Income (for common shares) $708 $502 $372
(in millions $) 31 Dec 2023 31 Dec 2022 31 Jan 2022 31 Dec 2020
Revenue
Total revenue $19457 $17967 $16471
Cost of revenue $8131 $7719 $6454
Gross Profit $11326 $10248 $10017
Operating activities
Research & development
Selling, general & administrative $7151 $6565 $6019
Total operating expenses $7342 $7355 $6132
Operating income $3984 $2893 $3885
Income from continuing operations
EBIT $3469 $2631 $3646
Income tax expense $937 $693 $787
Interest expense $232 $153 $164
Net income
Net income $2300 $1785 $2695
Income (for common shares) $2300 $1785 $2695
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Net income $718 $708 $502 $372
Operating activities
Depreciation $150 $144 $145 $128
Business acquisitions & disposals
Stock-based compensation $25 $60 $23 $14
Total cash flows from operations $1136 $1152 $722 $735
Investing activities
Capital expenditures -$197 -$161 -$184 -$163
Investments $56 $19 $19 -$98
Total cash flows from investing -$143 -$161 -$174 -$264
Financing activities
Dividends paid -$506 -$396 -$457 -$390
Sale and purchase of stock -$190 -$266 -$234 -$58
Net borrowings -$344 -$149 $111 $68
Total cash flows from financing -$992 -$846 -$580 -$375
Effect of exchange rate $14 -$13 -$16 -$4
Change in cash and equivalents $15 $132 -$48 $92
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Net income $2300 $1785 $2166 $2695
Operating activities
Depreciation $567 $545 $556 $539
Business acquisitions & disposals -$809 -$353
Stock-based compensation $122 $125 $135 $107
Total cash flows from operations $3745 $2556 $3325 $3719
Investing activities
Capital expenditures -$705 -$649 -$567 -$410
Investments -$4 -$148 -$19
Total cash flows from investing -$742 -$1601 -$592 -$779
Financing activities
Dividends paid -$1749 -$1691 -$1679 -$1654
Sale and purchase of stock -$748 -$890 -$896 -$602
Net borrowings -$314 $1647 -$175 -$564
Total cash flows from financing -$2793 -$952 -$2774 -$2919
Effect of exchange rate -$19 -$60 -$15 -$16
Change in cash and equivalents $191 -$57 -$56 $5
Fundamentals
Market cap $74.14B
Enterprise value $81.73B
Shares outstanding 823.37M
Revenue N/A
EBITDA N/A
EBIT N/A
Net Income N/A
Revenue Q/Q N/A
Revenue Y/Y N/A
P/E ratio N/A
EV/Sales N/A
EV/EBITDA N/A
EV/EBIT N/A
P/S ratio N/A
P/B ratio 16.31
Book/Share 5.52
Cash/Share 1.17
EPS N/A
ROA N/A
ROE N/A
Debt/Equity 25.35
Net debt/EBITDA N/A
Current ratio 1.11
Quick ratio 0.71